基诺美
化学
广告
嘧啶
选择性
体内
药物发现
结构-活动关系
化学合成
药理学
生物化学
组合化学
激酶
体外
医学
生物
生物技术
催化作用
作者
Jian‐kang Jiang,Xiuli Huang,Khalida Shamim,Paresma Patel,Arthur Lee,Amy Q. Wang,Kimloan Nguyen,Gregory J. Tawa,Gregory D. Cuny,Paul B. Yu,Wei Zheng,Xin Xu,Philip E.J. Sanderson,Wenwei Huang
标识
DOI:10.1016/j.bmcl.2018.09.006
摘要
The pyrazolo[1,5-a]pyrimidine LDN-193189 is a potent inhibitor of activin receptor-like kinase 2 (ALK2) but is nonselective for highly homologous ALK3 and shows only modest kinome selectivity. Herein, we describe the discovery of a novel series of potent and selective ALK2 inhibitors by replacing the quinolinyl with a 4-(sulfamoyl)naphthyl, yielding ALK2 inhibitors that exhibit not only excellent discrimination versus ALK3 but also high kinome selectivity. In addition, the optimized compound 23 demonstrates good ADME and in vivo pharmacokinetic properties.
科研通智能强力驱动
Strongly Powered by AbleSci AI